Discover the distinct benefits of Ozempic and Mounjaro in managing diabetes and facilitating weight loss. Ozempic, containing semaglutide, primarily targets type 2 diabetes through enhanced insulin secretion, while Mounjaro, with the dual-action ingredient tirzepatide, improves glycemic control by engaging both GLP-1 and GIP receptors. This guide compares their mechanisms, optimal dosing guidelines, and the common side effects to help patients make informed choices. Stay updated on the